Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agilent Technologies (NY:A)

116.03 -4.05 (-3.37%)
Streaming Delayed Price Updated: 12:11 PM EDT, Jul 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Agilent Technologies

< Previous 1 2 3 4 5 6 7 8 9 Next >
Agilent Names Simon May to Lead Diagnostics and Genomics Group
From Agilent Technologies Inc.
Via Business Wire
Agilent Receives Scientists' Choice Awards for Sustainability
From Agilent Technologies Inc.
Via Business Wire
Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
From Agilent Technologies Inc.
Via Business Wire
Agilent Technologies Inc. (NYSE: A) Highlighted for Surprising Price Action
Via Investor Brand Network
Agilent Brings Great Science to Life at Analytica 2024
From Agilent Technologies Inc.
Via Business Wire
Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics
From Agilent Technologies Inc.
Via Business Wire
Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence
From Agilent Technologies Inc.
Via Business Wire
Agilent Launches New Advanced Dilution System to Increase Lab Efficiency
From Agilent Technologies Inc.
Via Business Wire
Agilent Presents 2024 Darlene Solomon Award to University of Cambridge Researcher Joycelyn Tan
From Agilent Technologies Inc.
Via Business Wire
Agilent Technologies Inc. (NYSE: A) Records 52-Week High Wednesday Morning
Via Investor Brand Network
Agilent Presents Solutions Innovation Research Awards to Drexel University and Prairie View A&M University Researchers
From Agilent Technologies Inc.
Via Business Wire
Agilent Reports First-Quarter Fiscal Year 2024 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Cash Dividend of 23.6 Cents per Share
From Agilent Technologies Inc.
Via Business Wire
Agilent CEO Mike McMullen to Retire; Agilent CrossLab Group President Padraig McDonnell Named CEO-Elect
From Agilent Technologies Inc.
Via Business Wire
Agilent Ranked Among Top 50 Most Just Companies in America
From Agilent Technologies Inc.
Via Business Wire
Agilent Wins Two Scientists’ Choice Awards for Drug Discovery and Development Products
From Agilent Technologies Inc.
Via Business Wire
Agilent to Participate in TD Cowen Health Care Conference
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Collaboration with Incyte to Develop Advanced Companion Diagnostics in Hematology and Oncology
From Agilent Technologies Inc.
Via Business Wire
Agilent to Announce First-Quarter Fiscal Year 2024 Financial Results Feb. 27
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces New ProteoAnalyzer System
From Agilent Technologies Inc.
Via Business Wire
Agilent Named to Dow Jones Sustainability Indices for Ninth Consecutive Year
From Agilent Technologies Inc.
Via Business Wire
Agilent Makes Strategic Updates to Organizational Structure
From Agilent Technologies Inc.
Via Business Wire
Agilent to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Agilent Technologies Inc.
Via Business Wire
Agilent Again Named “Global Lighthouse” by World Economic Forum for Manufacturing Innovations
From Agilent Technologies Inc.
Via Business Wire
Agilent Resolve Raman Receives Multiple Recognitions for HazMat and CBRN Excellence
From Agilent Technologies Inc.
Via Business Wire
Agilent BioTek Cytation C10 Confocal Imaging Reader Enhanced with Innovative Water Immersion Technology
From Agilent Technologies Inc.
Via Business Wire
Agilent Reports Fourth-Quarter Fiscal Year 2023 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Agilent to Present at the Evercore ISI HealthCONx Conference
From Agilent Technologies Inc.
Via Business Wire
Agilent Increases Cash Dividend to 23.6 Cents per Share
From Agilent Technologies Inc.
Via Business Wire
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
From Agilent Technologies Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.